Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBVNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.86 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.7 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.12 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.7.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.390NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.319NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.572NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.397NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Q.3 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.523NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.116 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.38 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.340NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.437NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.452NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.400NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.16 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.46.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.37 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-16669.2Singapore
B.1.336NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.317NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.397NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.54NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DR.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.59NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ED.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used